1. Home
  2. AIN vs FTRE Comparison

AIN vs FTRE Comparison

Compare AIN & FTRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Albany International Corporation

AIN

Albany International Corporation

HOLD

Current Price

$56.79

Market Cap

1.5B

ML Signal

HOLD

Logo Fortrea Holdings Inc.

FTRE

Fortrea Holdings Inc.

HOLD

Current Price

$15.61

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIN
FTRE
Founded
1895
1996
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.5B
1.5B
IPO Year
1987
N/A

Fundamental Metrics

Financial Performance
Metric
AIN
FTRE
Price
$56.79
$15.61
Analyst Decision
Hold
Buy
Analyst Count
4
10
Target Price
$60.25
$15.50
AVG Volume (30 Days)
286.8K
1.3M
Earning Date
02-25-2026
02-26-2026
Dividend Yield
1.99%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,148,512,000.00
$2,759,900,000.00
Revenue This Year
N/A
$3.21
Revenue Next Year
N/A
$0.25
P/E Ratio
N/A
N/A
Revenue Growth
N/A
1.88
52 Week Low
$41.15
$3.97
52 Week High
$83.65
$18.67

Technical Indicators

Market Signals
Indicator
AIN
FTRE
Relative Strength Index (RSI) 55.23 43.25
Support Level $54.61 $15.49
Resistance Level $57.21 $17.20
Average True Range (ATR) 1.52 1.07
MACD -0.35 -0.21
Stochastic Oscillator 38.36 16.19

Price Performance

Historical Comparison
AIN
FTRE

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

About FTRE Fortrea Holdings Inc.

Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion. Fortrea has 19,000 staff members across 90 countries.

Share on Social Networks: